PREV — Preveceutical Medical Cashflow Statement
0.000.00%
Last trade - 00:00- CA$12.24m
- CA$16.90m
Annual cashflow statement for Preveceutical Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.73 | -1.48 | -1.27 | -1.17 | -1.69 |
| Depreciation | |||||
| Non-Cash Items | 0.702 | 0.754 | 0.44 | 0.395 | -0.995 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.593 | 0.495 | 0.527 | 0.343 | 0.952 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.426 | -0.223 | -0.297 | -0.427 | -1.72 |
| Capital Expenditures | -0.055 | — | — | -0.002 | -0.003 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.003 | 0.001 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.053 | 0.001 | 0 | -0.002 | -0.003 |
| Financing Cash Flow Items | — | -0.006 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.137 | 0.212 | 0.294 | 0.488 | 1.68 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.14 | -0.01 | -0.004 | 0.058 | -0.049 |